1. Home
  2. LGVN vs EDUC Comparison

LGVN vs EDUC Comparison

Compare LGVN & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • EDUC
  • Stock Information
  • Founded
  • LGVN 2014
  • EDUC 1965
  • Country
  • LGVN United States
  • EDUC United States
  • Employees
  • LGVN 25
  • EDUC N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • EDUC Consumer Specialties
  • Sector
  • LGVN Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • LGVN 11.5M
  • EDUC 11.4M
  • IPO Year
  • LGVN 2021
  • EDUC N/A
  • Fundamental
  • Price
  • LGVN $0.81
  • EDUC $1.11
  • Analyst Decision
  • LGVN Strong Buy
  • EDUC
  • Analyst Count
  • LGVN 3
  • EDUC 0
  • Target Price
  • LGVN $6.33
  • EDUC N/A
  • AVG Volume (30 Days)
  • LGVN 1.9M
  • EDUC 11.4K
  • Earning Date
  • LGVN 08-13-2025
  • EDUC 10-09-2025
  • Dividend Yield
  • LGVN N/A
  • EDUC N/A
  • EPS Growth
  • LGVN N/A
  • EDUC N/A
  • EPS
  • LGVN N/A
  • EDUC N/A
  • Revenue
  • LGVN $2,073,000.00
  • EDUC $31,304,000.00
  • Revenue This Year
  • LGVN N/A
  • EDUC N/A
  • Revenue Next Year
  • LGVN $51.48
  • EDUC N/A
  • P/E Ratio
  • LGVN N/A
  • EDUC N/A
  • Revenue Growth
  • LGVN 68.67
  • EDUC N/A
  • 52 Week Low
  • LGVN $0.63
  • EDUC $0.92
  • 52 Week High
  • LGVN $2.86
  • EDUC $2.49
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 30.47
  • EDUC 29.27
  • Support Level
  • LGVN $0.63
  • EDUC $1.03
  • Resistance Level
  • LGVN $0.94
  • EDUC $1.19
  • Average True Range (ATR)
  • LGVN 0.16
  • EDUC 0.07
  • MACD
  • LGVN -0.09
  • EDUC -0.02
  • Stochastic Oscillator
  • LGVN 11.37
  • EDUC 25.00

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: